NCT01088932

Multiple Dose Safety Study of SRX246 Capsules in Healthy Volunteers

Phase I, Double-Blind, Placebo-Controlled, Ascending, Multiple-Dose, Safety, Tolerability and Pharmacokinetic Study of SRX246 Capsules in Healthy Adult Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 24 (actual)
• Sponsor: Azevan Pharmaceuticals · Industry
• Sex: All
• Age: 18 Years – 55 Years
• Healthy volunteers: Accepted

Summary

This is a multiple dose clinical study to be conducted with SRX246 capsules to determine the safety, tolerability and pharmacokinetics of the drug over a 14 day dosing period.

Detailed description

This study is intended to evaluate the safety, tolerability and pharmacokinetic profile of multiple oral doses of SRX246 in healthy adult volunteers.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	SRX246	capsules

Timeline

• Start date: 2010-03-01
• Primary completion: 2010-06-01
• Completion: 2010-07-01
• First posted: 2010-03-18
• Last updated: 2010-07-20

Locations

1 site across 1 country: United States